249 related articles for article (PubMed ID: 28005705)
1. Denervation of the distal renal arterial branches vs. conventional main renal artery treatment: a randomized controlled trial for treatment of resistant hypertension.
Pekarskiy SE; Baev AE; Mordovin VF; Semke GV; Ripp TM; Falkovskaya AU; Lichikaki VA; Sitkova ES; Zubanova IV; Popov SV
J Hypertens; 2017 Feb; 35(2):369-375. PubMed ID: 28005705
[TBL] [Abstract][Full Text] [Related]
2. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
[TBL] [Abstract][Full Text] [Related]
3. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
Mathiassen ON; Vase H; Bech JN; Christensen KL; Buus NH; Schroeder AP; Lederballe O; Rickers H; Kampmann U; Poulsen PL; Hansen KW; Btker HE; Peters CD; Engholm M; Bertelsen JB; Lassen JF; Langfeldt S; Andersen G; Pedersen EB; Kaltoft A
J Hypertens; 2016 Aug; 34(8):1639-47. PubMed ID: 27228432
[TBL] [Abstract][Full Text] [Related]
4. Comparison of standard renal denervation procedure versus novel distal and branch vessel procedure with brachial arterial access.
Petrov I; Tasheva I; Garvanski I; Stankov Z; Simova I
Cardiovasc Revasc Med; 2019 Jan; 20(1):38-42. PubMed ID: 29843976
[TBL] [Abstract][Full Text] [Related]
5. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).
Fengler K; Rommel KP; Blazek S; Besler C; Hartung P; von Roeder M; Petzold M; Winkler S; Höllriegel R; Desch S; Thiele H; Lurz P
Circulation; 2019 Jan; 139(5):590-600. PubMed ID: 30586691
[TBL] [Abstract][Full Text] [Related]
6. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
[TBL] [Abstract][Full Text] [Related]
7. [Renal artery denervation for treating refractory hypertension].
Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A
J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance.
Ewen S; Cremers B; Meyer MR; Donazzan L; Kindermann I; Ukena C; Helfer AG; Maurer HH; Laufs U; Grassi G; Böhm M; Mahfoud F
J Hypertens; 2015 Dec; 33(12):2519-25. PubMed ID: 26485463
[TBL] [Abstract][Full Text] [Related]
10. Renal denervation for uncontrolled hypertension: critical review of the evidence.
Chen C; Upadhyay A
Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):114-122. PubMed ID: 27922849
[TBL] [Abstract][Full Text] [Related]
11. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.
Fengler K; Heinemann D; Okon T; Röhnert K; Stiermaier T; von Röder M; Besler C; Müller U; Höllriegel R; Schuler G; Desch S; Lurz P
Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060
[TBL] [Abstract][Full Text] [Related]
12. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
13. Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial.
Courand PY; Pereira H; Del Giudice C; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Vehier C; Lantelme P; Denolle T; Dourmap C; Halimi JM; Girerd X; Rossignol P; Zannad F; Ormezzano O; Vaisse B; Herpin D; Ribstein J; Bouhanick B; Mourad JJ; Ferrari E; Chatellier G; Sapoval M; Azarine A; Azizi M;
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018027
[TBL] [Abstract][Full Text] [Related]
14. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
[TBL] [Abstract][Full Text] [Related]
15. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
Ott C; Mahfoud F; Schmid A; Ewen S; Toennes SW; Meyer MR; Helfer AG; Maurer HH; Ditting T; Veelken R; Zivanovic I; Uder M; Böhm M; Schmieder RE
J Hypertens; 2016 Dec; 34(12):2475-2479. PubMed ID: 27607458
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
Ewen S; Dörr O; Ukena C; Linz D; Cremers B; Laufs U; Hamm C; Nef H; Bauer A; Mancia G; Böhm M; Mahfoud F
J Hypertens; 2015 Dec; 33(12):2512-8. PubMed ID: 26485461
[TBL] [Abstract][Full Text] [Related]
17. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Davies J; Basile J; Kirtane AJ; Wang Y; Lobo MD; Saxena M; Feyz L; Rader F; Lurz P; Sayer J; Sapoval M; Levy T; Sanghvi K; Abraham J; Sharp ASP; Fisher NDL; Bloch MJ; Reeve-Stoffer H; Coleman L; Mullin C; Mauri L;
Lancet; 2018 Jun; 391(10137):2335-2345. PubMed ID: 29803590
[TBL] [Abstract][Full Text] [Related]
18. [Renal denervation a treatment for resistant hypertension: a French experience].
Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience.
Fengler K; Höllriegel R; Okon T; Stiermaier T; Rommel KP; Blazek S; Besler C; von Roeder M; Petzold M; Schuler G; Lurz P
J Hypertens; 2017 Jun; 35(6):1310-1317. PubMed ID: 28441700
[TBL] [Abstract][Full Text] [Related]
20. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
Weber MA; Kirtane AJ; Weir MR; Radhakrishnan J; Das T; Berk M; Mendelsohn F; Bouchard A; Larrain G; Haase M; Diaz-Cartelle J; Leon MB
JACC Cardiovasc Interv; 2020 Feb; 13(4):461-470. PubMed ID: 32081240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
